The biological national security is facing a dramatic issue and it may be ripped from the page because American pharmaceutical companies and the health-care sector are not doing enough to secure biological data, particularly patient DNA information. The people in the nation are in danger of identify threat.
Several firms in China have set themselves up as DNA sequencing factories conducting testing for individuals and back office analysis for major American health-care firms and academic institutions.
The pharmaceutical sector could be stripped away as foreign competitors use massive American data sets to produce targeted therapies that are much more effective than current generation medicines. Foreign adversaries could use stolen American data to become quicker to come up with solutions to future pandemics or diseases like Zika and SARS. They could even create a solution that targets their own population but leaves out most Americans.
It is also reported that the US government isn’t doing enough to protect the biological security from a private sector.